What the study found
A pyrazolo[1,5-c]quinazoline scaffold, a tricyclic chemical structure, was shown to have activity at TLR7 and TLR8, two toll-like receptors involved in immune signaling. One compound showed moderate agonist activity, and three modified compounds acted as dual TLR7/8 antagonists.
Why the authors say this matters
The authors conclude that these findings add to structure-activity relationship knowledge for tricyclic TLR7/8 modulators, which they say will help in the discovery and optimization of new drug candidates. The study also notes that TLR7/8 agonists are potentially useful as vaccine adjuvants, while antagonists show activity against autoimmune diseases and cancer.
What the researchers tested
The researchers synthesized compound 23, a pyrazolo[1,5-c]quinazoline-based molecule, by analogy with lead agonists and antagonists reported in the literature. They then made a focused library of related compounds to examine how changes at the C1, C8, C9, and C10 positions affected human TLR7/8 activity.
What worked and what didn't
Compound 23 showed moderate agonist activity for both TLR7 and TLR8. After structural modification, none of the compounds retained agonist activity, but three compounds were identified as dual TLR7/8 antagonists.
What to keep in mind
The abstract does not describe detailed potency values, experimental conditions, or broader validation beyond the compounds tested. It also does not state whether the findings have been tested in living organisms or advanced toward clinical use.
Key points
- A pyrazolo[1,5-c]quinazoline compound showed moderate agonist activity at TLR7 and TLR8.
- A focused set of modified compounds was tested at the C1, C8, C9, and C10 positions.
- None of the modified compounds showed agonist activity.
- Three compounds were found to be dual TLR7/8 antagonists.
- The authors say the results add to structure-activity relationship knowledge for tricyclic TLR7/8 modulators.
Disclosure
- Research title:
- New pyrazoloquinazoline compounds showed mixed TLR7/8 activity
- Authors:
- K Ambarish Kumar, Yoshikazu Honda‐Okubo, Pradeep K. Das, Anshuman Dixit, KP Singh, David A. Winkler, Nikolai Petrovsky, Deepak B. Salunke
- Institutions:
- Institute of Life Sciences, Institute of Life Sciences, La Trobe University, Monash University, National Institute of Pharmaceutical Education and Research – Ahmedabad, Panjab University, Panjab University, Panjab University, Panjab University, Panjab University, University of Nottingham, Vaxine (Australia), Vaxine (Australia), West Australian Sleep Disorders Research Institute, West Australian Sleep Disorders Research Institute
- Publication date:
- 2026-04-21
- OpenAlex record:
- View
Get the weekly research newsletter
Stay current with scholarly research without reading academic papers — one filtered digest, every Friday.